Mesoblast | MSB - Debt


Mesoblast reported $135.14M in Debt for its fiscal semester ending in December of 2025.





Debt Change Date
Avita Medical AUD 46.05M 1.46M Dec/2025
Clinuvel Pharmaceuticals AUD 879.78K 189.09K Jun/2024
Cochlear AUD 235.7M 10.9M Jun/2025
CSL USD 11.96B 219M Dec/2024
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
PYC Therapeutics AUD 1.02M 185.07K Jun/2025
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Starpharma Holdings AUD 2.4M 73K Jun/2025
Telix Pharmaceuticals AUD 467.11M 48.85M Dec/2025